Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
Inki MoonTae Hwa GoJang Young KimDae Ryong KangSuk Ho SohnHyun-Jung LeeJae-Woong ChoiJun-Bean ParkHo-Young HwangHyung-Kwan KimYong Jin KimKyung-Hwan KimSeung-Pyo LeePublished in: PloS one (2022)
In this nationwide Korean AF population with a BPHV, DOAC was at least as effective and safe as warfarin for the prevention of systemic embolic events. These results suggest that DOAC may be an excellent alternative to warfarin in AF patients with BPHV.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- aortic valve
- mitral valve
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- aortic valve replacement
- transcatheter aortic valve replacement
- aortic stenosis
- heart failure
- transcatheter aortic valve implantation
- venous thromboembolism
- percutaneous coronary intervention
- cross sectional
- drug induced